Joseph S McCracken Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph S McCracken.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph S McCracken. Joseph S McCracken is Director in Savara Inc ($MSTX) and Director in LUMOS PHARMA, INC. ($NLNK) and Director in Kindred Biosciences, Inc. ($KIN) and Director in Nexvet Biopharma plc ($NVET).
Latest Insider Trading Transactions of Joseph S McCracken
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KIN, NLNK, NVET, SVRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | P | 1.45 | 68,965 | 99,999 | 168,337 | 99.4 K to 168.3 K (+69.40 %) |
| Jan 22 2021 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 4.44 | 48,500 | 215,340 | 48,500 | |
| Dec 17 2020 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | A | 1.23 | 40,000 | 49,200 | 40,000 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
| Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | McCracken Joseph S | Director | Grant | A | 0.00 | 709 | 0 | 709 | 0 to 709 |
| Jan 22 2020 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.84 | 48,500 | 477,240 | 48,500 | |
| Jan 22 2020 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.84 | 48,500 | 477,240 | 48,500 | |
| Dec 26 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | A | 1.59 | 12,000 | 19,080 | 12,000 | |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | M | 1.76 | 9,034 | 15,900 | 1,807 | |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | M | 1.46 | 5,860 | 8,556 | 0 | |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | M | 0.82 | 2,930 | 2,403 | 0 | |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Option Exercise | M | 0.82 | 21,682 | 17,779 | 0 | |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | M | 1.76 | 9,034 | 15,900 | 99,372 | 90.3 K to 99.4 K (+10.00 %) |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | M | 1.46 | 5,860 | 8,556 | 90,338 | 84.5 K to 90.3 K (+6.94 %) |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | M | 0.82 | 2,930 | 2,403 | 84,478 | 81.5 K to 84.5 K (+3.59 %) |
| Jul 08 2019 | SVRA | Savara Inc | McCracken Joseph S | Director | Buy | M | 0.82 | 21,682 | 17,779 | 81,548 | 59.9 K to 81.5 K (+36.22 %) |
| Feb 05 2019 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.91 | 48,500 | 480,635 | 48,500 | |
| Jun 26 2018 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 11.00 | 10,000 | 110,000 | 10,000 | |
| Apr 24 2018 | KIN | Kindred Bioscience ... | McCracken Joseph S | Director | Option Exercise | A | 9.65 | 41,890 | 404,239 | 41,890 | |
| Dec 19 2017 | MSTX | Savara Inc | McCracken Joseph S | Director | Option Exercise | A | 15.21 | 3,750 | 57,038 | 3,750 | |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Sell | D | 6.72 | 16,400 | 110,208 | 0 | 16.4 K to 0 (-100.00 %) |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 0 | |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 0 | |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 3,600 | 450 | 16,400 | 12.8 K to 16.4 K (+28.13 %) |
| Jul 05 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 12,800 | 12.3 K to 12.8 K (+4.07 %) |
| Jun 09 2017 | MSTX | Savara Inc | McCracken Joseph S | Director | Buy | P | 4.75 | 52,250 | 248,188 | 59,866 | 7.6 K to 59.9 K (+686.06 %) |
| Apr 04 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 500 | |
| Apr 04 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 12,300 | 11.8 K to 12.3 K (+4.24 %) |
| Jan 03 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 1,000 | |
| Jan 03 2017 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 11,800 | 11.3 K to 11.8 K (+4.42 %) |
| Oct 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 1,500 | |
| Oct 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 11,300 | 10.8 K to 11.3 K (+4.63 %) |
| Sep 07 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 3,600 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 3,600 | 450 | 0 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 2,000 | |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 3,600 | 450 | 10,800 | 7.2 K to 10.8 K (+50.00 %) |
| Jul 01 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 7,200 | 6.7 K to 7.2 K (+7.46 %) |
| Apr 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 2,500 | |
| Apr 04 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 6,700 | 6.2 K to 6.7 K (+8.06 %) |
| Jan 05 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 3,000 | |
| Jan 05 2016 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 6,200 | 5.7 K to 6.2 K (+8.77 %) |
| Oct 01 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 3,500 | |
| Oct 01 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 5,700 | 5.2 K to 5.7 K (+9.62 %) |
| Sep 08 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | A | 0.13 | 3,600 | 450 | 3,600 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 4,000 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 900 | 113 | 0 | |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 500 | 63 | 5,200 | 4.7 K to 5.2 K (+10.64 %) |
| Jul 02 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 900 | 113 | 4,700 | 3.8 K to 4.7 K (+23.68 %) |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 500 | 63 | 4,500 | |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Option Exercise | M | 0.13 | 900 | 113 | 900 | |
| May 20 2015 | NVET | Nexvet Biopharma p ... | McCracken Joseph S | Director | Buy | M | 0.13 | 1,400 | 175 | 3,800 | 2.4 K to 3.8 K (+58.33 %) |
Page: 1